微信公众号
证券之星APP
| 报告期 | 销售毛利率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2024-09-30 | -21.95% | -527.24% | 9.73% | 50/51 | 35.76% | 南华生物 | 68.03% | 行业排名> |
| 2024-06-30 | -24.31% | -1221.6% | -16.78% | 50/51 | 35.89% | 百诚医药 | 68.75% | 行业排名> |
| 2024-03-31 | -20.82% | 2.97% | -217.74% | 49/51 | 35.75% | 百诚医药 | 68.19% | 行业排名> |
| 2023-12-31 | -6.55% | -114.75% | -227.56% | 49/51 | 38.13% | 药康生物 | 67.61% | 行业排名> |
| 2023-09-30 | 5.14% | -88.64% | 136.98% | 49/51 | 39.87% | 药康生物 | 69.14% | 行业排名> |
| 2023-06-30 | 2.17% | -95.45% | 110.1% | 49/51 | 39.77% | 药康生物 | 68.49% | 行业排名> |
| 2023-03-31 | -21.46% | -142% | -148.31% | 48/51 | 38.93% | 药康生物 | 69.3% | 行业排名> |
| 2022-12-31 | 44.41% | -13.49% | -1.74% | 17/51 | 40.1% | 药康生物 | 71.38% | 行业排名> |
| 2022-09-30 | 45.2% | -4.9% | -5.14% | 16/51 | 41.1% | 药康生物 | 73.27% | 行业排名> |
| 2022-06-30 | 47.64% | -0.53% | -6.73% | 13/51 | 39.96% | 药康生物 | 75.32% | 行业排名> |
| 2022-03-31 | 51.08% | 2% | -0.5% | 8/51 | 38.57% | 药康生物 | 76.7% | 行业排名> |
| 2021-12-31 | 51.34% | -11.66% | 8.02% | 11/51 | 41.94% | 药康生物 | 74.33% | 行业排名> |
| 2021-09-30 | 47.52% | 2% | -0.79% | 17/51 | 43.07% | 南华生物 | 84.53% | 行业排名> |
| 2021-06-30 | 47.9% | -17.17% | -17.57% | 17/51 | 42.6% | 南华生物 | 83.19% | 行业排名> |
| 2020-12-31 | 58.11% | 49.33% | 49.33% | 7/51 | 38.51% | 南华生物 | 83.9% | 行业排名> |
| 2019-12-31 | 38.91% | -20.09% | -32.71% | 34/51 | 42.94% | 成都先导 | 79.36% | 行业排名> |
| 2019-06-30 | 57.83% | 4.77% | 18.76% | 7/51 | 45.09% | 成都先导 | 75.92% | 行业排名> |
| 2018-12-31 | 48.7% | 2% | -11.78% | 10/51 | 42.09% | 南华生物 | 78.74% | 行业排名> |
| 2018-06-30 | 55.2% | 2% | 2% | 6/51 | 43.98% | 成都先导 | 80.82% | 行业排名> |